U.S. markets closed
  • S&P 500

    +26.44 (+0.60%)
  • Dow 30

    +271.58 (+0.78%)
  • Nasdaq

    +114.58 (+0.78%)
  • Russell 2000

    +39.69 (+1.81%)
  • Crude Oil

    +0.01 (+0.01%)
  • Gold

    -2.40 (-0.13%)
  • Silver

    -0.11 (-0.42%)

    -0.0004 (-0.04%)
  • 10-Yr Bond

    +0.0330 (+2.79%)

    +0.0047 (+0.34%)

    +0.2960 (+0.27%)

    +1,031.61 (+2.58%)
  • CMC Crypto 200

    +29.64 (+3.04%)
  • FTSE 100

    -3.43 (-0.05%)
  • Nikkei 225

    +144.04 (+0.52%)

Boise Cascade (BCC) to Post Q1 Earnings: What's in Store?

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Boise Cascade Company BCC is slated to announce first-quarter 2021 results on May 6, after market close.

In the last reported quarter, its adjusted earnings topped the Zacks Consensus Estimate by 60%. The company’s top and bottom line grew 33.6% and 375.7%, respectively, from the prior-year quarter. Markedly, it surpassed earnings expectations in the last four quarters, the average surprise being 48%.

Trend in Estimate Revision

For the quarter to be reported, the Zacks Consensus Estimate for earnings per share has been upwardly revised to $2.50 from $1.91 over the past 30 days. The estimated figure indicates an increase of 296.8% from 63 cents per share reported in the year-ago quarter.

Factors to Consider

Boise Cascade’s earnings are expected to have increased in the first quarter as the company is experiencing robust demand in the housing market. Higher proportion in the single-family homes and accelerated demand for new residential construction across the United States might have helped the company’s performance. Also, pricing has continued to increase and is expected remain at elevated levels in early 2021.

The company is witnessing periodic short-term disruptions due to COVID-related restrictions, particularly for LVL and I-joists (together referred as EWP) as well as at Building Materials Distribution (BMD) centers. Nevertheless, rise in demand for new residential construction as well as repair-and-remodeling activity owing to low mortgage rates, continuation of work-from-home practices and favorable demographics are likely to have somewhat aided its top line.

Also, prices for commodity lumber and panel products are rising, which is likely to have supported the bottom-line performance.

Boise Cascade, L.L.C. Price and EPS Surprise

Boise Cascade, L.L.C. Price and EPS Surprise
Boise Cascade, L.L.C. Price and EPS Surprise

Boise Cascade, L.L.C. price-eps-surprise | Boise Cascade, L.L.C. Quote

What Our Model Indicates

Our proven model does not conclusively predict an earnings beat for Boise Cascade this time around. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. Unfortunately, that is not the case here, as you will see below.

Earnings ESP: Earnings ESP for Boise Cascade is 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Zacks Rank: The company currently has a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Stocks With Favorable Combination

Here are some companies in the Zacks Construction sector, which according to our model have the right combination of elements to post earnings beat in their respective quarters to be reported.

Louisiana-Pacific Corporation LPX has an Earnings ESP of +3.80% and a Zacks Rank #1.

TopBuild Corp. BLD has an Earnings ESP of +4.28% and a Zacks Rank #2.

Advanced Drainage Systems, Inc. WMS has an Earnings ESP of +2.63% and a Zacks Rank #2.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Advanced Drainage Systems, Inc. (WMS) : Free Stock Analysis Report

LouisianaPacific Corporation (LPX) : Free Stock Analysis Report

Boise Cascade, L.L.C. (BCC) : Free Stock Analysis Report

TopBuild Corp. (BLD) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research